谷胱甘肽
黄曲霉毒素
生物
内分泌学
内科学
DNA
谷胱甘肽S-转移酶
DNA加合物
致癌物
睾丸
毒性
DNA损伤
生物化学
酶
医学
食品科学
作者
Rene E. Sotomayor,Saura C. Sahu,Melissa C. Washington,Dennis M. Hinton,Ming W. Chou
标识
DOI:10.1002/(sici)1098-2280(1999)33:4<293::aid-em6>3.0.co;2-e
摘要
Fisher-344 male rats were fed 1.6 ppm of aflatoxin B1 (AFB1) continuously and intermittently for several weeks. At various time periods, DNA was isolated from the testes and livers and analyzed for AFB1-DNA adducts. The ability of the testis to detoxify AFB1 was also investigated by the glutathione S-transferase (GST) activity assay and compared with that of the liver. The levels of testicular AFB1-DNA adducts were 2.4 to 8.1 times lower than those of the liver after 4 to 16 weeks of continuous treatment and 2.2 to 46.2 times lower after 8 to 20 weeks of intermittent treatment. The testicular DNA adducts markedly decreased over time. By 16 weeks of continuous and 20 weeks of intermittent exposure, they had decreased 37 and 91%, respectively. In contrast, hepatic AFB1-DNA adducts increased four-fold from 4 to 16 weeks of continuous treatment but increased at a much slower rate after intermittent exposure. In both the liver and testis, significant levels of AFB1-DNA adducts persisted for at least 1 month after ending the treatment, suggesting that this type of lesion was poorly repaired. In control rats, the testis showed significantly higher GST activity than the liver. In treated rats, these differences were significant during the first 12 weeks of continuous treatment but not at later times. Tissue-specific differences such as germ-cell depletion and increased testicular detoxification may play an important role in the observed differential pattern of DNA adduct formation between the testis and liver. Environ. Mol. Mutagen. 33:293–302, 1999 © 1999 Wiley-Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI